US-based blood filtering technology producer ExThera Medical closed a $15.3m series B round yesterday that was led by medical device maker Fresenius Medical Care’s investment unit Fresenius Medical Care Ventures.

The round included the conversion of notes. Other investors have not been named.

ExThera is working on a device named Seraph Microbind Affinity Blood Filter, a technology that is able to remove a wide range of bacteria, viruses, toxins and pro-inflammaroty cytokines, a type of small proteins, from the blood…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?